These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. employer identification no.) | ||||||||||
|
|||||||||||
|
|
|
|||||||||
(Address of principal executive office) | (Zip code) |
Securities registered pursuant to Section 12(b) of the Act: | ||||||||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
þ | Accelerated filer | ☐ | |||||||||||
Non-accelerated filer | ☐ | Smaller reporting company |
|
|||||||||||
Emerging growth company |
|
Page | |||||
Item 1. Financial Statements
(Unaudited).
|
|||||
|
April 3, 2021 | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Accounts receivable, net of allowance of $464 and $331 as of October 2, 2021 and April 3, 2021, respectively |
|
|
|||||||||
Inventories
|
|
|
|||||||||
Prepaid expenses |
|
|
|||||||||
Other receivables |
|
|
|||||||||
Other current assets
|
|
|
|||||||||
Total current assets |
|
|
|||||||||
Property and equipment, net of accumulated depreciation of $1,655,084 and $1,561,613 as of October 2, 2021 and April 3, 2021, respectively |
|
|
|||||||||
Goodwill |
|
|
|||||||||
Intangible assets, net
|
|
|
|||||||||
Long-term investments |
|
|
|||||||||
Other non-current assets |
|
|
|||||||||
Total assets | $ |
|
$ |
|
|||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ |
|
$ |
|
|||||||
Accrued liabilities |
|
|
|||||||||
Current portion of long-term debt |
|
|
|||||||||
Other current liabilities |
|
|
|||||||||
Total current liabilities |
|
|
|||||||||
Long-term debt |
|
|
|||||||||
Other long-term liabilities |
|
|
|||||||||
Total liabilities |
|
|
|||||||||
Commitments and contingent liabilities
(Note 9)
|
|||||||||||
Stockholders’ equity: | |||||||||||
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding |
|
|
|||||||||
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 110,461 and 112,557 shares issued and outstanding at October 2, 2021 and April 3, 2021, respectively |
|
|
|||||||||
Accumulated other comprehensive income |
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Total stockholders’ equity |
|
|
|||||||||
Total liabilities and stockholders’ equity | $ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
|
October 3, 2020 |
|
October 3, 2020 | ||||||||||||||||||||
Revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Cost of goods sold |
|
|
|
|
|||||||||||||||||||
Gross profit |
|
|
|
|
|||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research and development |
|
|
|
|
|||||||||||||||||||
Selling, general and administrative |
|
|
|
|
|||||||||||||||||||
Other operating expense |
|
|
|
|
|||||||||||||||||||
Total operating expenses |
|
|
|
|
|||||||||||||||||||
Operating income |
|
|
|
|
|||||||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other income, net |
|
|
|
|
|||||||||||||||||||
Income before income taxes |
|
|
|
|
|||||||||||||||||||
Income tax expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Net income per share: | |||||||||||||||||||||||
Basic | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Weighted average shares of common stock outstanding: | |||||||||||||||||||||||
Basic |
|
|
|
|
|||||||||||||||||||
Diluted |
|
|
|
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
|
October 3, 2020 |
|
October 3, 2020 | ||||||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other comprehensive (loss) income, net of tax: | |||||||||||||||||||||||
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term investment nature |
(
|
|
(
|
|
|||||||||||||||||||
Reclassification adjustments, net of tax: | |||||||||||||||||||||||
Amortization of pension actuarial loss |
|
|
|
|
|||||||||||||||||||
Other comprehensive (loss) income |
(
|
|
(
|
|
|||||||||||||||||||
Total comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
Accumulated Other Comprehensive Income | Retained Earnings | ||||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||
Three Months Ended | Shares | Amount | Total | ||||||||||||||||||||||||||
Balance, July 3, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
Net income
|
— |
|
|
|
|
||||||||||||||||||||||||
Other comprehensive loss | — |
|
(
|
|
(
|
||||||||||||||||||||||||
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes
|
|
(
|
|
|
(
|
||||||||||||||||||||||||
Repurchase of common stock, including transaction costs
|
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||
Stock-based compensation
|
— |
|
|
|
|
||||||||||||||||||||||||
Balance, October 2, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
Balance, June 27, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
Net income
|
— |
|
|
|
|
||||||||||||||||||||||||
Other comprehensive income | — |
|
|
|
|
||||||||||||||||||||||||
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes
|
|
(
|
|
|
(
|
||||||||||||||||||||||||
Repurchase of common stock, including transaction costs
|
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||
Stock-based compensation
|
— |
|
|
|
|
||||||||||||||||||||||||
Balance, October 3, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
|
Accumulated Other Comprehensive Income | Retained Earnings | ||||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||
Six Months Ended | Shares | Amount | Total | ||||||||||||||||||||||||||
Balance, April 3, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
Net income
|
— |
|
|
|
|
||||||||||||||||||||||||
Other comprehensive loss | — |
|
(
|
|
(
|
||||||||||||||||||||||||
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes
|
|
(
|
|
|
(
|
||||||||||||||||||||||||
Issuance of common stock in connection with employee stock purchase plan
|
|
|
|
|
|
||||||||||||||||||||||||
Repurchase of common stock, including transaction costs
|
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||
Stock-based compensation
|
— |
|
|
|
|
||||||||||||||||||||||||
Balance, October 2, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
Balance, March 28, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
Net income
|
— |
|
|
|
|
||||||||||||||||||||||||
Other comprehensive income | — |
|
|
|
|
||||||||||||||||||||||||
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes
|
|
(
|
|
|
(
|
||||||||||||||||||||||||
Issuance of common stock in connection with employee stock purchase plan
|
|
|
|
|
|
||||||||||||||||||||||||
Cumulative-effect adoption of ASU 2016-13 | — |
|
|
(
|
(
|
||||||||||||||||||||||||
Repurchase of common stock, including transaction costs
|
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||
Stock-based compensation
|
— |
|
|
|
|
||||||||||||||||||||||||
Other | — |
|
|
(
|
(
|
||||||||||||||||||||||||
Balance, October 3, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
|
Six Months Ended | |||||||||||
|
October 3, 2020 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ |
|
$ |
|
|||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Depreciation |
|
|
|||||||||
Intangible assets amortization |
|
|
|||||||||
Deferred income taxes |
(
|
|
|||||||||
Stock-based compensation expense |
|
|
|||||||||
Other, net |
(
|
(
|
|||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable, net |
(
|
(
|
|||||||||
Inventories |
(
|
|
|||||||||
Prepaid expenses and other assets |
(
|
(
|
|||||||||
Accounts payable and accrued liabilities |
|
|
|||||||||
Income taxes payable and receivable |
(
|
|
|||||||||
Other liabilities |
(
|
(
|
|||||||||
Net cash provided by operating activities |
|
|
|||||||||
Cash flows from investing activities: | |||||||||||
Purchase of property and equipment |
(
|
(
|
|||||||||
Purchase of businesses, net of cash acquired |
(
|
(
|
|||||||||
Other investing activities |
|
|
|||||||||
Net cash used in investing activities |
(
|
(
|
|||||||||
Cash flows from financing activities: | |||||||||||
Payment of debt |
(
|
(
|
|||||||||
Proceeds from borrowings and debt issuances |
|
|
|||||||||
Repurchase of common stock, including transaction costs |
(
|
(
|
|||||||||
Proceeds from the issuance of common stock |
|
|
|||||||||
Tax withholding paid on behalf of employees for restricted stock units |
(
|
(
|
|||||||||
Other financing activities |
(
|
(
|
|||||||||
Net cash (used in) provided by financing activities |
(
|
|
|||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(
|
|
|||||||||
Net (decrease) increase in cash, cash equivalents and restricted cash |
(
|
|
|||||||||
Cash, cash equivalents and restricted cash at the beginning of the period |
|
|
|||||||||
Cash, cash equivalents and restricted cash at the end of the period | $ |
|
$ |
|
|||||||
Reconciliation of cash, cash equivalents and restricted cash: | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Restricted cash included in "Other current assets" and "Other non-current assets" |
|
|
|||||||||
Total cash, cash equivalents and restricted cash | $ |
|
$ |
|
|||||||
Supplemental disclosure of cash flow information: | |||||||||||
Capital expenditures included in liabilities | $ |
|
$ |
|
|
April 3, 2021 | ||||||||||
Raw materials | $ |
|
$ |
|
|||||||
Work in process |
|
|
|||||||||
Finished goods |
|
|
|||||||||
Total inventories | $ |
|
$ |
|
Intangible assets | $ |
|
|||
Goodwill |
|
||||
Net tangible assets
(1)
|
|
||||
Deferred tax liability, net |
(
|
||||
Total purchase price | $ |
|
Mobile Products | Infrastructure and Defense Products | Total | |||||||||||||||
Balance as of April 3, 2021
(1)
|
$ |
|
$ |
|
$ |
|
|||||||||||
Goodwill resulting from NextInput acquisition
(Note 4)
|
|
|
|
||||||||||||||
7Hugs measurement period adjustments |
(
|
|
(
|
||||||||||||||
Effect of changes in foreign currency exchange rates |
(
|
|
(
|
||||||||||||||
Balance as of October 2, 2021
(1)
|
$ |
|
$ |
|
$ |
|
|
April 3, 2021 | ||||||||||||||||||||||
Gross
Carrying Amount |
Accumulated
Amortization |
Gross
Carrying Amount |
Accumulated
Amortization |
||||||||||||||||||||
Developed technology | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Customer relationships |
|
|
|
|
|||||||||||||||||||
Technology licenses |
|
|
|
|
|||||||||||||||||||
Backlog |
|
|
|
|
|||||||||||||||||||
Trade names |
|
|
|
|
|||||||||||||||||||
In-process research and development |
|
N/A |
|
N/A | |||||||||||||||||||
Total
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
Total |
Quoted Prices In
Active Markets For Identical Assets (Level 1) |
Significant Other
Observable Inputs (Level 2) |
Significant
Unobservable Inputs (Level 3) |
||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
Marketable equity securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
Invested funds in deferred compensation plan
(1)
|
|
|
|
|
|||||||||||||||||||||||||||||||
April 3, 2021 | |||||||||||||||||||||||||||||||||||
Marketable equity securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
Invested funds in deferred compensation plan
(1)
|
|
|
|
|
|||||||||||||||||||||||||||||||
Contingent earn-out liability
(2)
|
(
|
|
|
(
|
|
April 3, 2021 | |||||||||||||
Term loan | $ |
|
$ |
|
||||||||||
4.375% senior notes due 2029 |
|
|
||||||||||||
3.375% senior notes due 2031 |
|
|
||||||||||||
Finance leases |
|
|
||||||||||||
Unamortized premium and issuance costs, net |
(
|
(
|
||||||||||||
Less current portion of long-term debt |
(
|
(
|
||||||||||||
Total long-term debt | $ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
|
October 3, 2020 |
|
October 3, 2020 | ||||||||||||||||||||
China | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
United States |
|
|
|
|
|||||||||||||||||||
Other Asia |
|
|
|
|
|||||||||||||||||||
Taiwan |
|
|
|
|
|||||||||||||||||||
Europe |
|
|
|
|
|||||||||||||||||||
Total revenue
|
$ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
|
October 3, 2020 | October 2, 2021 | October 3, 2020 | ||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
MP | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
IDP |
|
|
|
|
|||||||||||||||||||
Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Operating income (loss): | |||||||||||||||||||||||
MP | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
IDP |
|
|
|
|
|||||||||||||||||||
All other |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Operating income |
|
|
|
|
|||||||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other income, net |
|
|
|
|
|||||||||||||||||||
Income before income taxes | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
|
October 3, 2020 |
|
October 3, 2020 | ||||||||||||||||||||
Reconciliation of “All other” category: | |||||||||||||||||||||||
Stock-based compensation expense | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
Amortization of intangible assets |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Acquisition and integration related costs
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other (including (loss) gain on assets, start-up costs, restructuring related charges and other miscellaneous corporate overhead) |
(
|
|
(
|
(
|
|||||||||||||||||||
Loss from operations for “All other” | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
|
October 3, 2020 |
|
October 3, 2020 | ||||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Numerator for basic and diluted net income per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Denominator: | |||||||||||||||||||||||
Denominator for basic net income per share — weighted average shares
|
|
|
|
|
|||||||||||||||||||
Effect of dilutive securities: | |||||||||||||||||||||||
Stock-based awards
|
|
|
|
|
|||||||||||||||||||
Denominator for diluted net income per share — adjusted weighted average shares and assumed conversions
|
|
|
|
|
|||||||||||||||||||
Basic net income per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted net income per share | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | |||||||||||||||||||||||||||||||||||
|
% of
Revenue |
October 3, 2020 |
% of
Revenue |
Increase (Decrease) |
Percentage
Change |
||||||||||||||||||||||||||||||
Revenue | $ |
|
100.0 | % | $ |
|
100.0 | % | $ | 194,956 | 18.4 | % | |||||||||||||||||||||||
Cost of goods sold |
|
50.5 |
|
53.6 | 64,953 | 11.4 | |||||||||||||||||||||||||||||
Gross profit | 621,553 | 49.5 | 491,550 | 46.4 | 130,003 | 26.4 | |||||||||||||||||||||||||||||
Research and development |
|
12.6 |
|
14.8 | 2,035 | 1.3 | |||||||||||||||||||||||||||||
Selling, general and administrative |
|
7.4 |
|
10.3 | (15,883) | (14.5) | |||||||||||||||||||||||||||||
Other operating expense |
|
0.6 |
|
0.4 | 3,135 | 74.8 | |||||||||||||||||||||||||||||
Operating income | $ | 362,360 | 28.9 | % | $ | 221,644 | 20.9 | % | $ | 140,716 | 63.5 | % | |||||||||||||||||||||||
Six Months Ended | |||||||||||||||||||||||||||||||||||
|
% of Revenue | October 3, 2020 | % of Revenue | Increase (Decrease) | Percentage Change | ||||||||||||||||||||||||||||||
Revenue | $ |
|
100.0 | % | $ |
|
100.0 | % | $ | 517,856 | 28.0 | % | |||||||||||||||||||||||
Cost of goods sold |
|
50.6 |
|
55.8 | 167,459 | 16.3 | |||||||||||||||||||||||||||||
Gross profit | 1,167,736 | 49.4 | 817,339 | 44.2 | 350,397 | 42.9 | |||||||||||||||||||||||||||||
Research and development |
|
13.1 |
|
15.5 | 24,043 | 8.4 | |||||||||||||||||||||||||||||
Selling, general and administrative |
|
7.8 |
|
10.6 | (12,188) | (6.2) | |||||||||||||||||||||||||||||
Other operating expense |
|
0.6 |
|
1.1 | (6,564) | (31.9) | |||||||||||||||||||||||||||||
Operating income | $ | 659,462 | 27.9 | % | $ | 314,356 | 17.0 | % | $ | 345,106 | 109.8 | % |
Three Months Ended | ||||||||||||||||||||||||||
(In thousands, except percentages) |
|
October 3, 2020 | Increase |
Percentage
Change |
||||||||||||||||||||||
Revenue | $ |
|
$ |
|
$ | 241,403 | 32.0 | % | ||||||||||||||||||
Operating income |
|
|
122,731 | 46.7 | ||||||||||||||||||||||
Operating income as a % of revenue | 38.7 | % | 34.8 | % | ||||||||||||||||||||||
Six Months Ended | ||||||||||||||||||||||||||
(In thousands, except percentages) |
|
October 3, 2020 | Increase |
Percentage
Change |
||||||||||||||||||||||
Revenue | $ |
|
$ |
|
$ | 609,137 | 49.8 | % | ||||||||||||||||||
Operating income |
|
|
312,438 | 83.8 | ||||||||||||||||||||||
Operating income as a % of revenue | 37.4 | % | 30.5 | % |
Three Months Ended | ||||||||||||||||||||||||||
(In thousands, except percentages) |
|
October 3, 2020 | Decrease |
Percentage
Change |
||||||||||||||||||||||
Revenue | $ |
|
$ |
|
$ | (46,447) | (15.2) | % | ||||||||||||||||||
Operating income |
|
|
(16,666) | (25.1) | ||||||||||||||||||||||
Operating income as a % of revenue | 19.2 | % | 21.7 | % | ||||||||||||||||||||||
Six Months Ended | ||||||||||||||||||||||||||
(In thousands, except percentages) |
|
October 3, 2020 | Decrease |
Percentage
Change |
||||||||||||||||||||||
Revenue | $ |
|
$ |
|
$ | (91,281) | (14.6) | % | ||||||||||||||||||
Operating income |
|
|
(43,082) | (26.9) | ||||||||||||||||||||||
Operating income as a % of revenue | 22.0 | % | 25.6 | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
(In thousands) | October 2, 2021 | October 3, 2020 | October 2, 2021 | October 3, 2020 | |||||||||||||||||||
Interest expense | $ | (15,327) | $ | (23,486) | $ | (30,606) | $ | (42,335) | |||||||||||||||
Other income, net | 4,754 | 1,920 | 21,545 | 25,057 | |||||||||||||||||||
Income tax expense | (32,598) | (63,161) | (45,586) | (63,239) |
Summarized Balance Sheets | |||||||||||
(in thousands) | October 2, 2021 | April 3, 2021 | |||||||||
Due from Non-Guarantors | $ | 250,842 | $ | 532,440 | |||||||
Other current assets | 596,376 | 610,646 | |||||||||
Total current assets | $ | 847,218 | $ | 1,143,086 | |||||||
Non-current assets | $ | 2,594,143 | $ | 2,450,960 | |||||||
Current liabilities | $ | 421,551 | $ | 240,943 | |||||||
Payable to Non-Guarantors | $ | 535,124 | $ | 395,323 | |||||||
Other long-term liabilities | 1,884,107 | 1,855,343 | |||||||||
Total long-term liabilities | $ | 2,419,231 | $ | 2,250,666 |
Summarized Statement of Income | Six Months Ended | |||||||
(in thousands) | October 2, 2021 | |||||||
Revenue | $ | 558,845 | ||||||
Gross profit | $ | 131,649 | ||||||
Net loss from continuing operations | $ | (39,193) | ||||||
Net loss | $ | (39,193) |
Period |
Total number of shares purchased
(in thousands)
|
Average price paid per share |
Total number of shares purchased as part of publicly announced plans or programs
(in thousands)
|
Approximate dollar value of shares that may yet be purchased under the plans or programs | ||||||||||||||||||||||
July 4, 2021 to July 31, 2021 | 80 | $ | 191.34 | 80 | $ | 1,698.7 | million | |||||||||||||||||||
August 1, 2021 to August 28, 2021 | 547 | 185.28 | 547 | 1,597.3 | million | |||||||||||||||||||||
August 29, 2021 to October 2, 2021 | 581 | 183.50 | 581 | 1,490.6 | million | |||||||||||||||||||||
Total | 1,208 | $ | 184.82 | 1,208 | $ | 1,490.6 | million |
22 | |||||
31.1 | |||||
31.2 | |||||
32.1 | |||||
32.2 | |||||
101 |
The following materials from our Quarterly Report on Form 10-Q for the quarter ended
October 2, 2021, f
ormatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Income; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders' Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements
|
||||
104 |
The cover page from our Quarterly Report on Form 10-Q for the quarter ended
October 2, 2021,
formatted in iXBRL
|
Qorvo, Inc. | |||||||||||
Date: | November 4, 2021 | /s/ Mark J. Murphy | |||||||||
Mark J. Murphy | |||||||||||
Chief Financial Officer | |||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Dr. Rhines has served as Chair of the Board of Qorvo since November 2023 and has served on our Board of Directors since January 2015. From 1995 until 2015, he served as a director of TriQuint. Since March 2020, he has served as President and Chief Executive Officer of Cornami, Inc., a semiconductor processor company focused on fully homomorphic encryption. Since October 2019, he has served as Chief Executive Officer of Rhines Consultants, a consulting firm in the semiconductor, integrated circuit design and manufacturing fields. Dr. Rhines was also CEO Emeritus of Mentor, a Siemens Business, an electronic design automation company, until October 2020, having previously served as President and Chief Executive Officer of Mentor from its acquisition by Siemens Industry, Inc. in March 2017 until October 2018. He previously served as Chief Executive Officer of Mentor Graphics Corporation from 1993 and Chairman of its board of directors from 2000 until the acquisition of Mentor Graphics by Siemens in 2017. Prior to joining Mentor Graphics, he spent 21 years at Texas Instruments, a semiconductor manufacturer, with his most recent position as the Executive Vice President of its Semiconductor Group with responsibility for its worldwide semiconductor business. Dr. Rhines serves on the board of Silvaco Group Inc., a publicly-traded electronic design automation software company. He also served as a director of Cirrus Logic, Inc., a semiconductor company, from 1995 to 2009, as a director of Electronic System Design Alliance, a trade association for electronic design companies, from 1994 to 2019, and as a director of Semiconductor Research Corporation, a technology research consortium from 2002 until 2020. Dr. Rhines also served as a director of PTK Acquisition Corp., a special purpose acquisition company. Dr. Rhines brings to the Board and its committees over 50 years of experience in the semiconductor industry, including substantial operating experience and management expertise as a CEO of a publicly traded technology company. He also brings strong leadership skills and a significant understanding of international markets. | |||
Susan L. Spradley Age: 63 Director Since: 2017 Committees: ● Compensation ● Corporate Development ● Governance and Nominating | |||
Mr. Nelson has served on the Board of Directors since January 2015. From 2012 until 2015, he served as a director of TriQuint. An expert in wireless technology, in 2022 Mr. Nelson founded and is principal of Nelson Technology Partners, Inc., providing strategic and operational advice to communications companies. Since 2009, he has been the co-founder and principal of Tritech Sales and Services, LLC, a strategic product, business development and sales function consulting firm. In 2017, he co-founded Geoverse, LLC, a company which designs, deploys and manages in-building cellular LTE systems, and served as its Chief Executive Officer from June 2018 through April 2022. Mr. Nelson served as the Chief Technology Officer for Globetouch, Inc., a privately held global provider of 3G and LTE mobile broadband services for connected devices and IoT applications, from January 2015 to August 2017. He served as Executive Vice President and Chief Technology Officer of AT&T Wireless Services where, over a twenty-year career, he led the Technology Development Group responsible for the development and deployment of the first 3G networks in the United States. During his career, Mr. Nelson has worked closely with both national and international regulators and standards bodies on the creation of wireless specifications and standards. Mr. Nelson holds numerous patents covering broad and fundamental aspects of wireless communications. Mr. Nelson brings to the Board and its committees substantial experience in the wireless communications industry, including his extensive knowledge regarding the requirements of downstream customers. He also has significant technical expertise, such as his standards development experience, 4G and 5G network deployment experience, and a deep understanding of the regulatory environment applicable to our business. | |||
Mr. Bruggeworth has served as our President and Chief Executive Officer and as a director since Qorvo’s incorporation in December 2013. Prior to becoming a director of Qorvo, he was RFMD’s President and Chief Executive Officer and a director from January 2003 until January 2015, having previously served in several senior management positions at RFMD beginning in September 1999. From July 1983 to April 1999, Mr. Bruggeworth held several manufacturing and engineering positions at AMP Inc. (now TE Connectivity LTD), a supplier of electrical and electronic connection devices, most recently as Divisional Vice President of Global Computer and Consumer Electronics based in Hong Kong. Since 2007, Mr. Bruggeworth has served on the board of directors, including as lead independent director since May 2017, of MSA Safety Incorporated, a publicly traded global leader in the development, manufacture and supply of safety products that protect people and facility infrastructures. Since November 2022, Mr. Bruggeworth has served on the board of directors of Seagate Technology Holdings plc, a publicly traded provider of storage solutions. Mr. Bruggeworth served as the Chair of the Semiconductor Industry Association in 2021 and served as its Vice Chair in 2020. As our President and Chief Executive Officer, Mr. Bruggeworth understands our business and the challenges and issues that we face and brings to the Board strong leadership skills and substantial global business experience. Mr. Bruggeworth also has over 30 years of experience with respect to manufacturing, marketing and material sourcing for semiconductors and other electronic products. | |||
Judy Bruner Age: 65 Director Since: 2021 Committees: ● Audit (Chair) ● Governance and Nominating | |||
John R. Harding Age: 69 Director Since: 2015 Committees: ● Audit ● Corporate Development (Chair) | |||
David H. Y. Ho Age: 65 Director Since: 2015 Committees: ● Compensation ● Corporate Development |
Name & Principal Position | Year |
Salary
($) |
Bonus ($) |
Stock
Awards ($) |
Non-Equity
Incentive Plan Compensation ($) |
All Other
($) |
Total
Compensation ($) |
||||||||||||||||||||||||||||
Robert A. Bruggeworth President and Chief Executive Officer |
2024 | 994,695 | – | 10,500,004 | 1,308,459 | 13,251 | 12,816,409 | ||||||||||||||||||||||||||||
2023 | 956,437 | – | 9,999,943 | 726,354 | 11,022 | 11,693,756 | |||||||||||||||||||||||||||||
2022 | 920,332 | – | 7,649,886 | 1,491,674 | 10,792 | 10,072,684 | |||||||||||||||||||||||||||||
Grant A. Brown Senior Vice President and Chief Financial Officer |
2024 | 603,942 | – | 2,599,987 | 446,988 | 260,612 | 3,911,529 | ||||||||||||||||||||||||||||
2023 | 451,344 | 219,231 | 2,550,000 | 150,774 | 12,972 | 3,384,321 | |||||||||||||||||||||||||||||
Philip Chesley Senior Vice President and President of High Performance Analog |
2024 | 497,740 | – | 1,999,991 | 368,294 | 12,401 | 2,878,426 | ||||||||||||||||||||||||||||
2023 | 478,682 | – | 1,699,953 | 204,522 | 10,806 | 2,393,963 | |||||||||||||||||||||||||||||
2022 | 180,635 | – | 2,999,999 | 91,772 | 6,260 | 3,278,666 | |||||||||||||||||||||||||||||
Steven E. Creviston Senior Vice President and President of Connectivity and Sensors |
2024 | 582,831 | – | 2,300,087 | 431,256 | 12,547 | 3,326,721 | ||||||||||||||||||||||||||||
2023 | 560,414 | – | 2,300,001 | 239,400 | 10,878 | 3,110,693 | |||||||||||||||||||||||||||||
2022 | 539,259 | – | 2,300,117 | 491,642 | 10,438 | 3,341,456 | |||||||||||||||||||||||||||||
Paul J. Fego Senior Vice President of Global Operations |
2024 | 517,416 | – | 2,400,019 | 382,846 | 12,412 | 3,312,693 | ||||||||||||||||||||||||||||
2023 | 500,055 | – | 2,300,001 | 213,693 | 10,767 | 3,024,516 | |||||||||||||||||||||||||||||
2022 | 490,435 | – | 2,300,117 | 447,130 | 10,452 | 3,248,134 |
Customers
Customer name | Ticker |
---|---|
Teradyne, Inc. | TER |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
BRUGGEWORTH ROBERT A | - | 193,994 | 20,000 |
BRUGGEWORTH ROBERT A | - | 190,161 | 20,000 |
CREVISTON STEVEN E | - | 83,591 | 0 |
CREVISTON STEVEN E | - | 80,552 | 0 |
RHINES WALDEN C | - | 67,145 | 0 |
Brown Grant | - | 58,858 | 0 |
FEGO PAUL J | - | 40,988 | 0 |
FEGO PAUL J | - | 32,732 | 0 |
Chesley Philip | - | 29,539 | 0 |
Brown Grant | - | 27,896 | 0 |
Chesley Philip | - | 27,635 | 0 |
GARDNER JEFFERY R | - | 25,271 | 0 |
Harrison Gina | - | 21,601 | 0 |
Harrison Gina | - | 18,796 | 0 |
Stewart Frank P. | - | 12,020 | 0 |
Nelson Roderick | - | 7,692 | 0 |
HARDING JOHN R | - | 7,597 | 0 |
BRUNER JUDY | - | 5,606 | 0 |
LOWE ALAN S | - | 2,410 | 0 |
CLEMMER RICHARD L | - | 1,587 | 0 |